XML 46 R34.htm IDEA: XBRL DOCUMENT v3.25.2
STOCK INCENTIVE PLANS - RSU Narratives (Details) - USD ($)
$ in Millions
6 Months Ended
Jun. 20, 2025
Jun. 30, 2025
Jun. 30, 2024
Equity-classified restricted stock units      
Share-based Compensation Arrangement by Share-based Payment Award      
Granted (in shares)   144,820  
Share-based compensation arrangement by share-based payment award, award requisite service period 4 years    
Fair value of common stock issued to settle liability-classified restricted stock units   $ 0.3  
Equity-classified restricted stock units | Equity Classified      
Share-based Compensation Arrangement by Share-based Payment Award      
Share-based payment arrangement, nonvested award, cost not yet recognized, amount   $ 86.3  
Share-based compensation not yet recognized, recognition period (in years)   4 years 7 days  
Equity-classified restricted stock units | Liability Classfied      
Share-based Compensation Arrangement by Share-based Payment Award      
Share-based payment arrangement, nonvested award, cost not yet recognized, amount   $ 3.6  
Share-based compensation not yet recognized, recognition period (in years)   1 year 4 months 24 days  
Equity-classified restricted stock units | Class A Common Stock      
Share-based Compensation Arrangement by Share-based Payment Award      
Granted (in shares)   153,690  
Vested (in shares)   428,709  
Equity-classified restricted stock units | Class A Common Stock | 2021 Stock Plan      
Share-based Compensation Arrangement by Share-based Payment Award      
Granted (in shares)   153,690  
Vested (in shares)   230,064  
Stock options      
Share-based Compensation Arrangement by Share-based Payment Award      
Share-based compensation not yet recognized, recognition period (in years)   2 months 8 days  
Stock options | 2021 Stock Plan      
Share-based Compensation Arrangement by Share-based Payment Award      
Vesting period (in years)   4 years  
Stock options | Common stock      
Share-based Compensation Arrangement by Share-based Payment Award      
Shares repurchased (in shares)   0 0